CARDIOLA

Genetic Potential and Pharmacological Profile

The 'Cardiola' variety is the result of long-term breeding by VILAR, aimed at obtaining standardized raw plant material. Unlike wild-growing forms, this variety demonstrates high breeding uniformity, which is critical for the industrial cultivation of medicinal crops. The main technological value of 'Cardiola' lies in the stable accumulation of a complex of biologically active substances (BAS) in rhizomes and roots, which determines its demand in the pharmaceutical industry.

Agrobiological Features and Productivity

The breeding solutions incorporated into 'Cardiola' ensure a predictable plant development cycle. The crop is adapted to the specific requirements of medicinal plant cultivation, where the key factor is not just total biomass, but the concentration of essential oil and valepotriates. Cultivation experience shows that the variety responds effectively to intensive farming technologies, allowing for high yields of marketable raw material when drying and primary processing protocols are followed.

• Pharmacological specialization: bred to provide raw materials meeting pharmacopeia standards.
• Trait stability: high genetic purity ensures crop uniformity across the entire planting area.
• End-use: the primary processing focus is on rhizomes, which are rich in sedative components.

Practical application of the 'Cardiola' variety allows agricultural enterprises and farms to minimize risks associated with inconsistent medicinal raw material quality. The high concentration of active ingredients guarantees the demand for the product from end-users—processing plants manufacturing phytopharmaceutical products.